NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

PCR的全球市場:未來預測(qPCR,dPCR,單重,多重),企業管理/顧問指南,定制市場預測/分析(2021-2025)-新型冠狀病毒感染(COVID-19)包括診斷需求的影響

PCR Markets: Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets with Executive and Consultant Guides, Including Customized Forecasting and Analysis. Updated to include impact of COVID-19 Diagnostics 2021 to 2025

出版商 Howe Sound Research 商品編碼 974425
出版日期 內容資訊 英文 363 Pages
商品交期: 最快1-2個工作天內
價格
PCR的全球市場:未來預測(qPCR,dPCR,單重,多重),企業管理/顧問指南,定制市場預測/分析(2021-2025)-新型冠狀病毒感染(COVID-19)包括診斷需求的影響 PCR Markets: Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets with Executive and Consultant Guides, Including Customized Forecasting and Analysis. Updated to include impact of COVID-19 Diagnostics 2021 to 2025
出版日期: 2020年12月08日內容資訊: 英文 363 Pages
簡介

本報告分析了全球PCR(聚合器鏈反應)市場的最新趨勢和未來前景,概述了技術,主要應用領域,主要市場推廣/限制因素以及近期技術發展/市場擴展。我們將為您提供信息,例如變動,主要公司的概況,總體市場規模趨勢,按國家,應用和技術分類的詳細趨勢,以及對行業利益相關者的建議。

目錄

市場指南

  • 形勢分析
  • 企業管理和營銷人員指南
  • 投資分析師和管理顧問指南

第1章簡介/市場定義

  • 什麼是PCR技術?
  • PCR測試和各種綜合症測試
  • 市場定義
  • 分析方法
  • 美國醫療市場和臨床測試的前景
    • 在美國用於臨床測試的Medicare支出

第2章PCR(聚合□鏈反應):PCR技術指南

  • 概念
    • 方法
  • 使用領域
    • 特定DNA的判斷
    • DNA測量
    • 醫療/診斷應用
  • PCR:利弊
  • 各種PCR
    • 輕鬆更換
    • 數位PCR
    • 等溫PCR

第3章行業概述

  • 動態市場進入公司
    • 教育機構實驗室
    • 診斷測試開發人員
    • 基因組儀器供應商
    • 製藥/試劑供應商
    • 獨立實驗室
    • 公共(國家/地區)實驗室
    • 醫院實驗室
    • 醫生實驗室
    • 審計機構
    • 認證機構

第4章市場趨勢

  • 市場促進因素
    • 新標準
    • 價格沿價格曲線下降
    • 多路復用
    • 症候群的診斷:市場進一步增長的前景
    • "遺傳暴風雪"
  • 市場抑制因素
    • 成本曲線
    • 其他因素
    • 全身性疾病
  • 診斷技術的發展
    • 測量曲線
    • 診斷部門角色的變化
    • 醫院診斷部門的獨立性
    • 出現混亂
    • 未來5年的趨勢展望

第5章PCR市場的最新趨勢

第6章主要PCR公司簡介

  • Abbott Diagnostics (Alere)
  • Accelerate Diagnostics
  • Agilent
  • Alveo Technologies
  • Applied BioCode
  • Atlas Genetics
  • Aus Diagnostics
  • BD Diagnostics
  • Biocartis
  • BioFire Diagnostics
  • bioMérieux
  • Bioneer
  • Bio-Rad Laboratories
  • Bosch Healthcare Solutions GmbH
  • Bruker
  • Cepheid
  • Curetis
  • Diagenode Diagnostics
  • Diasorin
  • Fluidigm
  • Fusion Genomics
  • GenePOC Diagnostics
  • GenMark Dx
  • Hologic
  • Invetech
  • Janssen Diagnostics
  • Karius
  • Lexigene
  • Luminex
  • Mesa Biotech
  • Mobidiag
  • Nanomix
  • Panagene
  • Precipio
  • Primerdesign
  • Prominex
  • Qiagen (Statdx)
  • Quantumdx
  • Roche Molecular Diagnostics
  • Seegene
  • Stilla Technologies
  • Siemens Healthineers (Fast Track Diagnostics)
  • SkylineDx
  • T2 Biosystems
  • Thermo Fisher
  • Veramarx
  • XCR Diagnostics

第7章PCR市場

  • 全球PCR市場概述:按國家

第8章全球PCR市場:按應用

  • 全球市場概述:按應用
  • PCR多重
  • PCR單重
  • PCR研究
  • PCR單C19
  • 其他PCR

第9章全球PCR市場:按技術

  • 全球市場概述:按技術分類
  • qPCR
  • dPCR
  • 單C19 PCR

附錄

  • 美國Medicare準確性:臨床檢查費用表(2020)
目錄

OVERVIEW:

COVID-19 Diagnostics is driving PCR into a dominant technology role and spurring the growth of new PCR based technologies. Will thermal cycling become obsolete?

Are singleplex tests going to be obsolete? Will routine cancer screening become a reality? Will diagnostics move into the Physician's Office or even the Home? Will digital PCR become the new lab standard?

Our facts and support = Your success.

The report forecasts the market size out to 2024 with the only analysis available that breaks out Singleplex and Multiplex testing markets. PCR has proved itself in the market. And the new generation of PCR, digital PCR promises to keep that success going. Driven even faster by the huge demand for pandemic diagnostics. New levels of sensitivity have implications for Liquid Biopsy and Cancer Screening markets. Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance. Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

i. Market Guides

  • iA. Situation Analysis
  • iB. Guide for Executives and Marketing Staff
  • iC. Guide for Investment Analysts and Management Consultants

1. Introduction and Market Definition

  • 1.1. What are PCR Technologies?
  • 1.2. PCR and Syndromic Testing
  • 1.3. Market Definition
    • 1.3.1. Market Size
    • 1.3.2. Currency
    • 1.3.3. Years
  • 1.4. Methodology
    • 1.4.1. Authors
    • 1.4.2. Sources
  • 1.5. U.S. Medical Market and laboratory Testing - Perspective
    • 1.4.1. U.S. Medicare Expenditures for Laboratory Testing

2. PCR-Guide to PCR Technologies

  • 2.1. Concepts
    • 2.1.1. Method
  • 2.2. Applications
    • 2.2.1. Finding Specific DNA
    • 2.2.2. Measuring DNA
    • 2.2.3. Medical and diagnostic applications
      • 2.2.3.1. Carrier, prenatal and tissue typing
      • 2.2.3.2. Cancer Diagnosis and Management
      • 2.2.3.3. Infectious disease-New Levels of Accuracy and Sensitivity
      • 2.2.3.4. Forensic applications
      • 2.2.3.5. Science and Research
  • 2.3. PCR-Advantages and Disadvantages
  • 2.4. Different Types of PCR
    • 2.4.1. Simple Changes
      • 2.4.1.1. Multiplex-PCR
      • 2.4.1.2. VNTR PCR
      • 2.4.1.3. Asymmetric PCR
      • 2.4.1.4. Long PCR
      • 2.4.1.5. Nested PCR
      • 2.4.1.6. Quantitative PCR
      • 2.4.1.7. Hot-start PCR
      • 2.4.1.8. Touchdown PCR
      • 2.4.1.9. Assembly PCR
      • 2.4.1.10. Colony PCR
      • 2.4.1.11. Suicide PCR
      • 2.4.1.12. Cold PCR
    • 2.4.2. Digital PCR
      • 2.4.2.1. Droplet Digital PCR
      • 2.4.2.2. Comparison between dPCR and Real-Time PCR (qPCR)
      • 2.4.2.3. Digital PCR in Use
      • 2.4.2.4. Digital PCR Commercial History
    • 2.4.3. Isothermal PCR

3. Industry Overview

  • 3.1. Players in a Dynamic Market
    • 3.1.1. Academic Research Lab
    • 3.1.2. Diagnostic Test Developer
    • 3.1.3. Genomic Instrumentation Supplier
      • 3.1.3.1. Cell Separation and Viewing Instrumentation Supplier
    • 3.1.4. Pharmaceutical/Reagent Supplier
    • 3.1.5. Independent Testing Lab
    • 3.1.6. Public National/regional lab
    • 3.1.7. Hospital lab
    • 3.1.8. Physician Lab
    • 3.1.9. Audit Body
    • 3.1.10. Certification Body

4. Market Trends

  • 4.1. Factors Driving Growth
    • 4.1.1. A New Standard
    • 4.1.2. Down the Curve We Go
    • 4.1.3. Multiplexing
    • 4.1.4. Syndromic Diagnostics Looks Unstoppable
    • 4.1.5. The Genetic Blizzard
  • 4.2. Factors Limiting Growth
    • 4.2.1. The Cost Curve
    • 4.2.2. The Other Guys
    • 4.2.3. Systemic Roadblocks
  • 4.3. Diagnostic Technology Development
    • 4.3.1. The Instrumentation Curve
    • 4.3.2. Shifting Role of Diagnostics
    • 4.3.3. Diagnostics Moves Out of the Hospital
    • 4.3.4. Disruption Looms
    • 4.3.5. The Next Five Years

5. PCR Recent Developments

  • 5.1. Recent Developments-Importance and How to Use This Section
    • 5.1.1. Importance of These Developments
    • 5.1.2. How to Use This Section
      • Scope Fluidics Secures €6.2M Supporting Rapid MDx
      • Quidel Expects SARS-CoV-2 Testing Demand to Continue 'Through 2022, and Beyond'
      • Malaria Assays Use CRISPR for Point-of-Care Multispecies Detection
      • Fluidigm Saliva Test for SARS-CoV-2 Uses Extraction-free RT-PCR
      • Visby Medical Gonorrhea Test Wins $19M AMR Diagnostic Competition
      • HelixBind Receives $3M NIH Grant to Expand Bloodstream Infection Dx Platform
      • Israel's Nucleix Targeting US Market With Noninvasive Bladder, Lung Cancer Assays
      • Thermo Fisher Sees Many Complementary Offerings in Qiagen Combination
      • DxTerity Gets CE Mark for At-Home Blood Sample Collection Device
      • Fetal Cell-Based NIPT by Droplet Digital PCR Demonstrated in Japanese Pilot Study
      • ChromaCode Raises $28M based on new High Definition PCR Technology
      • ddPCR Used for Fast and Low-Cost NIPT Screening
      • Study Validates ChromaCode HDPCR™ Testing for Tick-Borne Pathogens
      • Bio-Rad's ddPCR MSI RUO Assay is available
      • ctDNA Monitoring Is Important for BRAF-Mutant Melanoma
      • Sysmex Inostics Liquid Biopsy Demonstrates Two-fold Higher Detection
      • QIAGEN Plans for Next-Generation Digital PCR Systems
      • Bioneer HIV-1 Dx Kit Gets Korea FDA Approval
      • New PCR Technology: Transfer-PCR (tPCR) Applications
      • NimaGen Licenses PCR Tech from Salisbury NHS Foundation Trust
      • Natera Applies Massively Multiplexed PCR to Kidney Transplants
      • Paragon Genomics, MGI Tech Form Distribution Alliance
      • Synlab Pharma, Biotype Collaborate on Gastrointestinal, Endometrial Cancers
      • Qiagen, NeuMoDx Ink Partnership, Merger Agreement
      • Bruker to Acquire Majority in Hain Lifescience GmbH
      • Curetis to Cut 30 Percent of Workforce as Part of Strategic Restructuring
      • Cancer Early Detection Firm Ark Launches With $40M Series A Investment
      • PredictImmune Wins £100K Grant for Study of IBD Prognostic
      • Biocartis, AstraZeneca Partner on European Lung Cancer Biomarker Study
      • llumina Ventures Leads €16M Series A Investment in Digital PCR Firm Stilla Technologies
      • Bio-Rad Wins USDA Food Safety Testing Contract
      • Luminex, XCR Diagnostics Sign Nucleic Acid Amplification Tech Licensing Deal

6. Profiles of Key PCR Companies

  • Abbott Diagnostics (Alere)
  • Accelerate Diagnostics
  • Agilent
  • Alveo Technologies
  • Applied BioCode
  • Atlas Genetics
  • Aus Diagnostics
  • BD Diagnostics
  • Biocartis
  • BioFire Diagnostics
  • bioMérieux
  • Bioneer
  • Bio-Rad Laboratories
  • Bosch Healthcare Solutions GmbH
  • Bruker
  • Cepheid
  • Curetis
  • Diagenode Diagnostics
  • Diasorin
  • Fluidigm
  • Fusion Genomics
  • GenePOC Diagnostics
  • GenMark Dx
  • Hologic
  • Invetech
  • Janssen Diagnostics
  • Karius
  • Lexigene
  • Luminex
  • Mesa Biotech
  • Mobidiag
  • Nanomix
  • Panagene
  • Precipio
  • Primerdesign
  • Prominex
  • Qiagen (Statdx)
  • Quantumdx
  • Roche Molecular Diagnostics
  • Seegene
  • Stilla Technologies
  • Siemens Healthineers (Fast Track Diagnostics)
  • SkylineDx
  • T2 Biosystems
  • Thermo Fisher
  • Veramarx
  • XCR Diagnostics

7. The PCR Markets

  • 7.1. PCR-Global Market Overview by Country
    • 7.1.1. Table-Global Market by Country
    • 7.1.2. Chart - Global Market by Country

8. Global PCR Markets-By Application

  • 8.1. Global Market by Application - Overview
    • 8.1.1. Table-Global Market by Application
    • 8.1.2. Chart-Global Market by Application-Base/Final Comparison
    • 8.1.3. Chart-Global Market by Application-Base Year
    • 8.1.4. Chart-Global Market by Application-Final Year
    • 8.1.4. Chart-Global Market by Application-Share by Year
  • 8.2. PCR Clinical Multiplex
    • 8.2.1. Table PCR Clinical Multiplex Testing-by Country
    • 8.2.2. Chart - PCR Clinical Multiplex Testing Growth
  • 8.3. PCR Clinical Singleplex
    • 8.3.1. Table PCR Clinical Singleplex Testing-by Country
    • 8.3.2. Chart - PCR Clinical Singleplex Testing Growth
  • 8.4. PCR Research
    • 8.4.1. Table PCR Research-by Country
    • 8.4.2. Chart - PCR Research Growth
  • 8.5. PCR Single C19
    • 8.5.1. Table PCR Single C19-by Country
    • 8.5.2. Chart - PCR Single C19 Growth
  • 8.6. PCR Other
    • 8.6.1. Table PCR Other-by Country
    • 8.6.2. Chart - PCR Other Growth

9. Global PCR Markets-By Technology

  • 9.1. Global Market by Technology - Overview
    • 9.1.1. Table-Global Market by Technology
    • 9.1.2. Chart-Global Market by Technology-Base/Final Comparison
    • 9.1.3. Chart-Global Market by Technology-Base Year
    • 9.1.4. Chart-Global Market by Technology-Final Year
    • 9.1.4. Chart-Global Market by Technology-Share by Year
  • 9.2. qPCR
    • 9.2.1. Table qPCR-by Country
    • 9.2.2. Chart - qPCR Growth
  • 9.3. dPCR
    • 9.3.1. Table dPCR-by Country
    • 9.3.2. Chart - dPCR Growth
  • 9.4. Single C19 PCR
    • 9.4.1. Table Single C19 PCR-by Country
    • 9.4.2. Chart - Single C19 PCR Growth

Appendices

  • I. United States Medicare System: 2020 Clinical Laboratory Fees Schedule

Table of Tables

  • Table 2: Lab Spending 2014 to 2024
  • Table 3: Market Players by Type
  • Table 4: Five Factors Driving Growth
  • Table 5: Three Factors Limiting Growth
  • Table 6: Global PCR Market by Region
  • Table 7: Global Market by Application
  • Table 8: PCR Clinical Multiplex by Country
  • Table 9: PCR Clinical Singleplex by Country
  • Table 10: PCR Research by Country
  • Table 11: PCR Single C19 by Country
  • Table 12: PCR Other by Country
  • Table 13: Global Market by Technology
  • Table 14: qPCR by Country
  • Table 15: dPCR by Country
  • Table 16: Single C19 PCR by Country
  • Table 17: 2020 Clinical Lab Fee Schedule
  • Figure 2: Clinical Lab Spending 2014 to 2024
  • Figure 3: The PCR Process
  • Figure 4: Creation of Sample Droplets for Digital PCR
  • Figure 5: Comparing Syndromic and Targeted Testing
  • Figure 6: Comparing The New Diagnostics and Traditional Testing
  • Figure 7: Growth rates of PCR Diagnostic Segments
  • Figure 8: Base year Global Market Share Chart
  • Figure 9: PCR Market by Application - Base vs. final
  • Figure 10: PCR Market Base year
  • Figure 11: PCR Market Final Year
  • Figure 12: Application Share by Year
  • Figure 13: PCR Clinical Multiplex Testing Growth
  • Figure 14: PCR Clinical Singleplex Testing Growth
  • Figure 15: PCR Research Growth
  • Figure 16: PCR Single C19 Growth
  • Figure 17: PCR Other Growth
  • Figure 18: PCR Market by Technology - Base vs. Final
  • Figure 19: PCR Market Base Year
  • Figure 20: PCR Market Final Year
  • Figure 21: Technology Share by Year
  • Figure 22: qPCR Growth
  • Figure 23: dPCR Growth
  • Figure 24: Single C19 PCR Growth